monoclonal antibody

Potential new treatment for Alzheimer’s disease

By on
amyloid cleared from brain by aducanumab

Aducanumab is an exciting potentially new treatment for Alzheimer’s disease and may possibly be the first potential cure.

A human monoclonal antibody, aducanumab, has been shown to remove amyloid beta plaques from the brains of patients with early or mild Alzheimer’s disease. The drug was more effective at higher doses. This was shown using PET brain scans (see below).

Tags: 

Pages